Chao‐Sheng Lo

Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice

Shuiling Zhao, Anindya Ghosh, Chao‐Sheng Lo et al. · Endocrinology · 2017 · 116 citations · Full text

Medicine, Nephrology, Pharmacology +16

Angiotensin-(1–7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice

Yixuan Shi, Chao‐Sheng Lo, Ranjit S. Padda et al. · Clinical Science · 2014 · 95 citations

Medicine, Nephrology, Pharmacology +17

Angiotensin-(1-7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?

Ranjit Singh Padda Yixuan Shi, Chao‐Sheng Lo · Journal of Diabetes & Metabolism · 2015 · 75 citations · Full text

Medicine, Endocrinology, Pharmacology +9

Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice

Kana N. Miyata, Chao‐Sheng Lo, Shuiling Zhao et al. · Clinical Science · 2021 · 65 citations · Full text

Medicine, Nephrology, Pharmacology +17

Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice

Chao‐Sheng Lo, Fang Liu, Yixuan Shi et al. · American Journal of Physiology-Renal Physiology · 2011 · 63 citations

Medicine, Nephrology, Pharmacology +16